company string | company_tickers list | cik string | sic string | office string | industry string | exchanges list | filing_type string | filing_date string | filing_accession_number string | filing_processed bool | parsed_toc_keys string | parsed_prospectus_summary_valid bool | parsed_prospectus_summary string | parsed_prospectus_summary_word_count int64 | parsed_risk_factors_valid bool | parsed_risk_factors string | parsed_risk_factors_word_count int64 | parsed_legal_matters_valid bool | parsed_legal_matters string | parsed_legal_matters_word_count int64 | filing_url string | filing_images list |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SPECIFICITY, INC. | [
"SPTY"
] | 0001840102 | 7311 | 07 Trade & Services | Services-Advertising Agencies | [
"OTC"
] | S-1/A | 2024-03-19 00:00:00 | 0001520138-24-000117 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840102/000152013824000117/spec_s1a.htm | [] |
SPECIFICITY, INC. | [
"SPTY"
] | 0001840102 | 7311 | 07 Trade & Services | Services-Advertising Agencies | [
"OTC"
] | S-1 | 2024-02-05 00:00:00 | 0001520138-24-000055 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840102/000152013824000055/spec_s1.htm | [] |
SPECIFICITY, INC. | [
"SPTY"
] | 0001840102 | 7311 | 07 Trade & Services | Services-Advertising Agencies | [
"OTC"
] | S-1 | 2022-09-13 00:00:00 | 0001520138-22-000418 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840102/000152013822000418/spty-2022_s1.htm | [] |
SPECIFICITY, INC. | [
"SPTY"
] | 0001840102 | 7311 | 07 Trade & Services | Services-Advertising Agencies | [
"OTC"
] | S-1 | 2022-05-20 00:00:00 | 0001520138-22-000218 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840102/000152013822000218/spty-04282022_s1.htm | [] |
SPECIFICITY, INC. | [
"SPTY"
] | 0001840102 | 7311 | 07 Trade & Services | Services-Advertising Agencies | [
"OTC"
] | S-1/A | 2021-09-14 00:00:00 | 0001520138-21-000541 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840102/000152013821000541/spec-09082021_s1a.htm | [] |
SPECIFICITY, INC. | [
"SPTY"
] | 0001840102 | 7311 | 07 Trade & Services | Services-Advertising Agencies | [
"OTC"
] | S-1/A | 2021-09-08 00:00:00 | 0001520138-21-000525 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840102/000152013821000525/spec-09082021_s1a.htm | [] |
SPECIFICITY, INC. | [
"SPTY"
] | 0001840102 | 7311 | 07 Trade & Services | Services-Advertising Agencies | [
"OTC"
] | S-1/A | 2021-08-23 00:00:00 | 0001520138-21-000465 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840102/000152013821000465/spec-08202021_s1a.htm | [] |
SPECIFICITY, INC. | [
"SPTY"
] | 0001840102 | 7311 | 07 Trade & Services | Services-Advertising Agencies | [
"OTC"
] | S-1/A | 2021-08-02 00:00:00 | 0001520138-21-000373 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840102/000152013821000373/spec-07292021_s1.htm | [] |
SPECIFICITY, INC. | [
"SPTY"
] | 0001840102 | 7311 | 07 Trade & Services | Services-Advertising Agencies | [
"OTC"
] | S-1 | 2021-06-23 00:00:00 | 0001520138-21-000330 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840102/000152013821000330/spec-06172021_s1.htm | [] |
PMGC Holdings Inc. | [
"ELAB"
] | 0001840563 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2025-11-26 00:00:00 | 0001213900-25-114961 | true | ABOUT THIS PROSPECTUS; MARKET DATA; PROSPECTUS SUMMARY; THE RESALE OFFERING; RISK FACTORS; SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS; USE OF PROCEEDS; MARKET PRICE OF OUR COMMON STOCK AND RELATED STOCKHOLDER MATTERS; PRIVATE PLACEMENT OF WARRANTS; MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS; BUSINESS; CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS; MANAGEMENT; EXECUTIVE COMPENSATION; PRINCIPAL STOCKHOLDERS; SELLING SHAREHOLDERS; DESCRIPTION OF SECURITIES; PLAN OF DISTRIBUTION; EXPERTS; LEGAL MATTERS; WHERE YOU CAN FIND MORE INFORMATION; INFORMATION INCORPORATED BY REFERENCE; INDEX TO FINANCIAL STATEMENTS | false | ./parsed_sections/prospectus_summary/2025/ELAB_pmgc_prospectus_summary.txt | 3 | true | ./parsed_sections/risk_factors/2025/ELAB_pmgc_risk_factors.txt | 89,478 | true | ./parsed_sections/legal_matters/2025/ELAB_pmgc_legal_matters.txt | 22,860 | https://www.sec.gov/Archives/edgar/data/0001840563/000121390025114961/ea0266089-s1a1_pmgchold.htm | [
"https://www.sec.gov/Archives/edgar/data/0001840563/000121390025114961/image_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001840563/000121390025114961/image_002.jpg"
] |
PMGC Holdings Inc. | [
"ELAB"
] | 0001840563 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2025-11-26 00:00:00 | 0001213900-25-114958 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840563/000121390025114958/ea0266119-s1a2_pmgchold.htm | [] |
PMGC Holdings Inc. | [
"ELAB"
] | 0001840563 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2025-10-16 00:00:00 | 0001213900-25-099277 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840563/000121390025099277/ea0261065-s1_pmgchold.htm | [] |
PMGC Holdings Inc. | [
"ELAB"
] | 0001840563 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2025-10-15 00:00:00 | 0001213900-25-099178 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840563/000121390025099178/ea0261113-s1a1_pmgchold.htm | [] |
PMGC Holdings Inc. | [
"ELAB"
] | 0001840563 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2025-09-22 00:00:00 | 0001213900-25-089709 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840563/000121390025089709/ea0256572-s1_pmgchold.htm | [] |
PMGC Holdings Inc. | [
"ELAB"
] | 0001840563 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2025-04-07 00:00:00 | 0001213900-25-029401 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840563/000121390025029401/ea0236301-s1a1_pmgchold.htm | [] |
PMGC Holdings Inc. | [
"ELAB"
] | 0001840563 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2025-02-12 00:00:00 | 0001213900-25-012352 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840563/000121390025012352/ea0229836-s1_pmgchold.htm | [] |
PMGC Holdings Inc. | [
"ELAB"
] | 0001840563 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2024-09-19 00:00:00 | 0001213900-24-080004 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840563/000121390024080004/ea0215049-s1a2_elevailabs.htm | [] |
PMGC Holdings Inc. | [
"ELAB"
] | 0001840563 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2024-09-16 00:00:00 | 0001213900-24-078712 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840563/000121390024078712/ea0214442-s1a1_elevailabs.htm | [] |
PMGC Holdings Inc. | [
"ELAB"
] | 0001840563 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2024-09-06 00:00:00 | 0001213900-24-076586 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840563/000121390024076586/ea0212635-s1_elevailabs.htm | [] |
PMGC Holdings Inc. | [
"ELAB"
] | 0001840563 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2023-11-09 00:00:00 | 0001213900-23-085076 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840563/000121390023085076/ea188013-s1a2_elevailabs.htm | [] |
PMGC Holdings Inc. | [
"ELAB"
] | 0001840563 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2023-11-06 00:00:00 | 0001213900-23-083596 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840563/000121390023083596/ea187698-s1a1_elevailabs.htm | [] |
PMGC Holdings Inc. | [
"ELAB"
] | 0001840563 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2023-09-29 00:00:00 | 0001213900-23-080647 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840563/000121390023080647/ea185873-s1_elevailabs.htm | [] |
Envoy Medical, Inc. | [
"COCHW"
] | 0001840877 | 3842 | 08 Industrial Applications and Services | Orthopedic, Prosthetic & Surgical Appliances & Supplies | [
"Nasdaq"
] | S-1 | 2025-12-18 00:00:00 | 0001213900-25-123367 | true | ABOUT THIS PROSPECTUS; FREQUENTLY USED TERMS; CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS; PROSPECTUS SUMMARY; THE OFFERING; RISK FACTORS; USE OF PROCEEDS; DILUTION; CAPITALIZATION; MARKET PRICE, TICKER SYMBOL AND DIVIDEND INFORMATION; BUSINESS; MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS; MANAGEMENT; EXECUTIVE COMPENSATION; CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS; BENEFICIAL OWNERSHIP OF SECURITIES; DESCRIPTION OF OUR SECURITIES; DESCRIPTION OF SECURITIES WE ARE OFFERING; MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS; SECURITIES ACT AND CONTRACTUAL RESTRICTIONS ON RESALE OF SECURITIES; PLAN OF DISTRIBUTION; LEGAL MATTERS; EXPERTS; WHERE YOU CAN FIND MORE INFORMATION; INDEX TO CONSOLIDATED FINANCIAL STATEMENTS | false | ./parsed_sections/prospectus_summary/2025/COCHW_envoy_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2025/COCHW_envoy_risk_factors.txt | 9,393 | false | ./parsed_sections/legal_matters/2025/COCHW_envoy_legal_matters.txt | 29,447 | https://www.sec.gov/Archives/edgar/data/0001840877/000121390025123367/ea0268759-s1_envoy.htm | [
"https://www.sec.gov/Archives/edgar/data/0001840877/000121390025123367/image_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001840877/000121390025123367/image_002.jpg",
"https://www.sec.gov/Archives/edgar/data/0001840877/000121390025123367/image_003.jpg",
"https://www.sec.gov/Archives/edgar/data/0001840877/000121390025123367/image_004.jpg",
"https://www.sec.gov/Archives/edgar/data/0001840877/000121390025123367/image_005.jpg",
"https://www.sec.gov/Archives/edgar/data/0001840877/000121390025123367/image_006.jpg"
] |
Envoy Medical, Inc. | [
"COCHW"
] | 0001840877 | 3842 | 08 Industrial Applications and Services | Orthopedic, Prosthetic & Surgical Appliances & Supplies | [
"Nasdaq"
] | S-1/A | 2025-12-01 00:00:00 | 0001213900-25-116721 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840877/000121390025116721/ea0267041-s1a1_envoy.htm | [] |
Envoy Medical, Inc. | [
"COCHW"
] | 0001840877 | 3842 | 08 Industrial Applications and Services | Orthopedic, Prosthetic & Surgical Appliances & Supplies | [
"Nasdaq"
] | S-1 | 2025-10-17 00:00:00 | 0001213900-25-099775 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840877/000121390025099775/ea0261409-s1_envoy.htm | [] |
Envoy Medical, Inc. | [
"COCHW"
] | 0001840877 | 3842 | 08 Industrial Applications and Services | Orthopedic, Prosthetic & Surgical Appliances & Supplies | [
"Nasdaq"
] | S-1/A | 2024-04-25 00:00:00 | 0001213900-24-036229 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840877/000121390024036229/ea0203133-02.htm | [] |
Envoy Medical, Inc. | [
"COCHW"
] | 0001840877 | 3842 | 08 Industrial Applications and Services | Orthopedic, Prosthetic & Surgical Appliances & Supplies | [
"Nasdaq"
] | S-1/A | 2024-04-05 00:00:00 | 0001213900-24-030821 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840877/000121390024030821/ea0203133-01.htm | [] |
Envoy Medical, Inc. | [
"COCHW"
] | 0001840877 | 3842 | 08 Industrial Applications and Services | Orthopedic, Prosthetic & Surgical Appliances & Supplies | [
"Nasdaq"
] | S-1/A | 2024-02-15 00:00:00 | 0001213900-24-014271 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840877/000121390024014271/fs12024a1_envoymed.htm | [] |
Envoy Medical, Inc. | [
"COCHW"
] | 0001840877 | 3842 | 08 Industrial Applications and Services | Orthopedic, Prosthetic & Surgical Appliances & Supplies | [
"Nasdaq"
] | S-1 | 2024-01-18 00:00:00 | 0001213900-24-004577 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840877/000121390024004577/fs12024_envoymed.htm | [] |
Envoy Medical, Inc. | [
"COCHW"
] | 0001840877 | 3842 | 08 Industrial Applications and Services | Orthopedic, Prosthetic & Surgical Appliances & Supplies | [
"Nasdaq"
] | S-1/A | 2021-02-19 00:00:00 | 0001104659-21-025855 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840877/000110465921025855/tm213438-4_s1a.htm | [] |
Envoy Medical, Inc. | [
"COCHW"
] | 0001840877 | 3842 | 08 Industrial Applications and Services | Orthopedic, Prosthetic & Surgical Appliances & Supplies | [
"Nasdaq"
] | S-1 | 2021-02-08 00:00:00 | 0001104659-21-014526 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001840877/000110465921014526/tm213438-2_s1.htm | [] |
Pasithea Therapeutics Corp. | [
"KTTAW"
] | 0001841330 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2025-11-26 00:00:00 | 0001213900-25-115595 | true | ABOUT THIS PROSPECTUS; CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS; PROSPECTUS SUMMARY; THE OFFERING; RISK FACTORS; USE OF PROCEEDS; DILUTION; DESCRIPTION OF CAPITAL STOCK; DESCRIPTION OF SECURITIES WE ARE OFFERING; PLAN OF DISTRIBUTION; INFORMATION INCORPORATED BY REFERENCE; WHERE YOU CAN FIND MORE INFORMATION; LEGAL MATTERS; EXPERTS | false | ./parsed_sections/prospectus_summary/2025/KTTAW_pasithea_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2025/KTTAW_pasithea_risk_factors.txt | 3,755 | false | ./parsed_sections/legal_matters/2025/KTTAW_pasithea_legal_matters.txt | 3,816 | https://www.sec.gov/Archives/edgar/data/0001841330/000121390025115595/ea0267537-s1a1_pasithea.htm | [
"https://www.sec.gov/Archives/edgar/data/0001841330/000121390025115595/image_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001841330/000121390025115595/image_002.jpg"
] |
Pasithea Therapeutics Corp. | [
"KTTAW"
] | 0001841330 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2025-11-18 00:00:00 | 0001213900-25-111842 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001841330/000121390025111842/ea0266093-s1_pasithea.htm | [] |
Pasithea Therapeutics Corp. | [
"KTTAW"
] | 0001841330 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2025-05-01 00:00:00 | 0001213900-25-038088 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001841330/000121390025038088/ea0239642-s1_pasithea.htm | [] |
Pasithea Therapeutics Corp. | [
"KTTAW"
] | 0001841330 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2021-12-09 00:00:00 | 0001213900-21-064451 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001841330/000121390021064451/ea151934-s1_pasitheathe.htm | [] |
Pasithea Therapeutics Corp. | [
"KTTAW"
] | 0001841330 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2021-09-13 00:00:00 | 0001213900-21-047497 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001841330/000121390021047497/ea147228-s1a6_pasitheatherap.htm | [] |
Pasithea Therapeutics Corp. | [
"KTTAW"
] | 0001841330 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2021-09-10 00:00:00 | 0001213900-21-047436 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001841330/000121390021047436/ea147024-s1a5_pasitheatherap.htm | [] |
Pasithea Therapeutics Corp. | [
"KTTAW"
] | 0001841330 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2021-08-27 00:00:00 | 0001213900-21-045117 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001841330/000121390021045117/ea145577-s1a4_pasitheatherap.htm | [] |
Pasithea Therapeutics Corp. | [
"KTTAW"
] | 0001841330 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2021-08-06 00:00:00 | 0001213900-21-040632 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001841330/000121390021040632/ea144160-s1a3_pasitheatherap.htm | [] |
Pasithea Therapeutics Corp. | [
"KTTAW"
] | 0001841330 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2021-06-22 00:00:00 | 0001213900-21-033448 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001841330/000121390021033448/ea142979-s1a2_pasitheatherap.htm | [] |
Pasithea Therapeutics Corp. | [
"KTTAW"
] | 0001841330 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2021-06-04 00:00:00 | 0001213900-21-030994 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001841330/000121390021030994/ea141883-s1a1_pasitheatherap.htm | [] |
Pasithea Therapeutics Corp. | [
"KTTAW"
] | 0001841330 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2021-04-13 00:00:00 | 0001213900-21-021386 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001841330/000121390021021386/ea139314-s1_pasitheatherap.htm | [] |
Maze Therapeutics, Inc. | [
"MAZE"
] | 0001842295 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1 | 2025-10-17 00:00:00 | 0001193125-25-242526 | true | About This Prospectus; Prospectus Summary; Risk Factors; Special Note Regarding Forward-Looking Statements; Use of Proceeds; Selling Stockholders; Plan of Distribution; Description of Capital Stock; Legal Matters; Experts; Where You Can Find Additional Information; Incorporation of Certain Information by Reference | true | ./parsed_sections/prospectus_summary/2025/MAZE_maze_prospectus_summary.txt | 1,517 | true | ./parsed_sections/risk_factors/2025/MAZE_maze_risk_factors.txt | 466 | true | ./parsed_sections/legal_matters/2025/MAZE_maze_legal_matters.txt | 30 | https://www.sec.gov/Archives/edgar/data/0001842295/000119312525242526/d67735ds1.htm | [
"https://www.sec.gov/Archives/edgar/data/0001842295/000119312525242526/g67735g54z20.jpg",
"https://www.sec.gov/Archives/edgar/data/0001842295/000119312525242526/g67735g27k64.jpg"
] |
Maze Therapeutics, Inc. | [
"MAZE"
] | 0001842295 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2025-01-30 00:00:00 | 0001193125-25-016039 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001842295/000119312525016039/d769642ds1a.htm | [] |
Maze Therapeutics, Inc. | [
"MAZE"
] | 0001842295 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2025-01-27 00:00:00 | 0001193125-25-012638 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001842295/000119312525012638/d769642ds1a.htm | [] |
Maze Therapeutics, Inc. | [
"MAZE"
] | 0001842295 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1 | 2025-01-07 00:00:00 | 0001193125-25-002851 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001842295/000119312525002851/d769642ds1.htm | [] |
Estrella Immunopharma, Inc. | [
"ESLAW"
] | 0001844417 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2026-01-22 00:00:00 | 0001213900-26-006410 | true | null | false | null | 0 | false | ./parsed_sections/risk_factors/2023/ESLAW_estrella_risk_factors.txt | 20,373 | false | null | 0 | https://www.sec.gov/Archives/edgar/data/0001844417/000121390026006410/ea0269161-03.htm | [] |
Estrella Immunopharma, Inc. | [
"ESLAW"
] | 0001844417 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2026-01-16 00:00:00 | 0001213900-26-005233 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844417/000121390026005233/ea0269161-02.htm | [] |
Estrella Immunopharma, Inc. | [
"ESLAW"
] | 0001844417 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1 | 2025-12-22 00:00:00 | 0001213900-25-124247 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844417/000121390025124247/ea0269161-01.htm | [] |
Estrella Immunopharma, Inc. | [
"ESLAW"
] | 0001844417 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2023-12-18 00:00:00 | 0001213900-23-096259 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844417/000121390023096259/fs12023a2_estrella.htm | [] |
Estrella Immunopharma, Inc. | [
"ESLAW"
] | 0001844417 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2023-11-13 00:00:00 | 0001213900-23-086235 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844417/000121390023086235/fs12023a1_estrella.htm | [] |
Estrella Immunopharma, Inc. | [
"ESLAW"
] | 0001844417 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1 | 2023-10-11 00:00:00 | 0001013762-23-002940 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844417/000101376223002940/fs12023_estrella.htm | [] |
Estrella Immunopharma, Inc. | [
"ESLAW"
] | 0001844417 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2021-07-09 00:00:00 | 0001104659-21-090553 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844417/000110465921090553/tm2121773d1_s1a.htm | [] |
Estrella Immunopharma, Inc. | [
"ESLAW"
] | 0001844417 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2021-07-01 00:00:00 | 0001104659-21-088194 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844417/000110465921088194/tm2120747-1_s1a.htm | [] |
Estrella Immunopharma, Inc. | [
"ESLAW"
] | 0001844417 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2021-06-11 00:00:00 | 0001104659-21-080274 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844417/000110465921080274/tm2116800d6_s1a.htm | [] |
Estrella Immunopharma, Inc. | [
"ESLAW"
] | 0001844417 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2021-05-28 00:00:00 | 0001104659-21-074205 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844417/000110465921074205/tm2116800d4_s1a.htm | [] |
Estrella Immunopharma, Inc. | [
"ESLAW"
] | 0001844417 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2021-05-25 00:00:00 | 0001104659-21-071821 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844417/000110465921071821/tm2116800d3_s1a.htm | [] |
Estrella Immunopharma, Inc. | [
"ESLAW"
] | 0001844417 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2021-05-18 00:00:00 | 0001104659-21-068705 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844417/000110465921068705/tm2116800d1_s1a.htm | [] |
Estrella Immunopharma, Inc. | [
"ESLAW"
] | 0001844417 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2021-05-07 00:00:00 | 0001104659-21-062618 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844417/000110465921062618/tm2112670d3_s1a.htm | [] |
Estrella Immunopharma, Inc. | [
"ESLAW"
] | 0001844417 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2021-04-12 00:00:00 | 0001104659-21-048847 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844417/000110465921048847/tm2112670d1_s1a.htm | [] |
Estrella Immunopharma, Inc. | [
"ESLAW"
] | 0001844417 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1/A | 2021-03-29 00:00:00 | 0001104659-21-042669 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844417/000110465921042669/tm2110799d1_s1a.htm | [] |
Estrella Immunopharma, Inc. | [
"ESLAW"
] | 0001844417 | 2836 | 03 Life Sciences | Biological Products, (No Diagnostic Substances) | [
"Nasdaq"
] | S-1 | 2021-02-19 00:00:00 | 0001104659-21-025854 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844417/000110465921025854/tm215878d1_s1.htm | [] |
QT IMAGING HOLDINGS, INC. | [
"QTIWW"
] | 0001844505 | 3845 | 08 Industrial Applications and Services | Electromedical & Electrotherapeutic Apparatus | [
"OTC"
] | S-1/A | 2025-12-29 00:00:00 | 0001628280-25-058960 | true | ABOUT THIS PROSPECTUS; CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS; SUMMARY; RISK FACTORS; USE OF PROCEEDS; PRIVATE PLACEMENT OF SHARES OF COMMON STOCK AND WARRANTS; DIVIDEND POLICY; DETERMINATION OF OFFERING PRICE; SUMMARY HISTORICAL FINANCIAL INFORMATION OF QT IMAGING; MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS; BUSINESS; MANAGEMENT; EXECUTIVE COMPENSATION; CERTAIN RELATIONSHIPS AND; OTHER MATERIAL AGREEMENTS; PRINCIPAL SECURITYHOLDERS; SELLING SECURITYHOLDERS; DESCRIPTION OF OUR SECURITIES; MATERIAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES; PLAN OF DISTRIBUTION; LEGAL MATTERS; EXPERTS; WHERE YOU CAN FIND MORE INFORMATION; INDEX TO FINANCIAL STATEMENTS | true | ./parsed_sections/prospectus_summary/2025/QTIWW_qt_prospectus_summary.txt | 7,207 | false | ./parsed_sections/risk_factors/2025/QTIWW_qt_risk_factors.txt | 41,392 | false | ./parsed_sections/legal_matters/2025/QTIWW_qt_legal_matters.txt | 22 | https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229.htm | [
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g1.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g2.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g3.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g4.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g5.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g6.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g7.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g8.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g9.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g10.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g11.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g12.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g13.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g14.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g15.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g16.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g17.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g18.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g19.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g20.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g21.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g22.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g23.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g24.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g25.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g26.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g27.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g28.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g29.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g30.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g31.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g32.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g33.jpg",
"https://www.sec.gov/Archives/edgar/data/0001844505/000162828025058960/qti-20251229_g34.jpg"
] |
QT IMAGING HOLDINGS, INC. | [
"QTIWW"
] | 0001844505 | 3845 | 08 Industrial Applications and Services | Electromedical & Electrotherapeutic Apparatus | [
"OTC"
] | S-1 | 2025-11-03 00:00:00 | 0001628280-25-048373 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844505/000162828025048373/qti-20251103.htm | [] |
QT IMAGING HOLDINGS, INC. | [
"QTIWW"
] | 0001844505 | 3845 | 08 Industrial Applications and Services | Electromedical & Electrotherapeutic Apparatus | [
"OTC"
] | S-1/A | 2025-01-31 00:00:00 | 0001628280-25-003316 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844505/000162828025003316/qti-20250131.htm | [] |
QT IMAGING HOLDINGS, INC. | [
"QTIWW"
] | 0001844505 | 3845 | 08 Industrial Applications and Services | Electromedical & Electrotherapeutic Apparatus | [
"OTC"
] | S-1 | 2025-01-16 00:00:00 | 0001628280-25-001723 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844505/000162828025001723/qti-20250116.htm | [] |
QT IMAGING HOLDINGS, INC. | [
"QTIWW"
] | 0001844505 | 3845 | 08 Industrial Applications and Services | Electromedical & Electrotherapeutic Apparatus | [
"OTC"
] | S-1/A | 2024-05-20 00:00:00 | 0001193125-24-141936 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844505/000119312524141936/d823386ds1a.htm | [] |
QT IMAGING HOLDINGS, INC. | [
"QTIWW"
] | 0001844505 | 3845 | 08 Industrial Applications and Services | Electromedical & Electrotherapeutic Apparatus | [
"OTC"
] | S-1/A | 2024-05-16 00:00:00 | 0001193125-24-140730 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844505/000119312524140730/d823386ds1a.htm | [] |
QT IMAGING HOLDINGS, INC. | [
"QTIWW"
] | 0001844505 | 3845 | 08 Industrial Applications and Services | Electromedical & Electrotherapeutic Apparatus | [
"OTC"
] | S-1/A | 2024-04-24 00:00:00 | 0001193125-24-110124 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844505/000119312524110124/d823386ds1a.htm | [] |
QT IMAGING HOLDINGS, INC. | [
"QTIWW"
] | 0001844505 | 3845 | 08 Industrial Applications and Services | Electromedical & Electrotherapeutic Apparatus | [
"OTC"
] | S-1 | 2024-04-02 00:00:00 | 0001193125-24-084445 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844505/000119312524084445/d823386ds1.htm | [] |
QT IMAGING HOLDINGS, INC. | [
"QTIWW"
] | 0001844505 | 3845 | 08 Industrial Applications and Services | Electromedical & Electrotherapeutic Apparatus | [
"OTC"
] | S-1/A | 2021-09-21 00:00:00 | 0001193125-21-278451 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844505/000119312521278451/d33994ds1a.htm | [] |
QT IMAGING HOLDINGS, INC. | [
"QTIWW"
] | 0001844505 | 3845 | 08 Industrial Applications and Services | Electromedical & Electrotherapeutic Apparatus | [
"OTC"
] | S-1/A | 2021-09-20 00:00:00 | 0001193125-21-276654 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844505/000119312521276654/d33994ds1a.htm | [] |
QT IMAGING HOLDINGS, INC. | [
"QTIWW"
] | 0001844505 | 3845 | 08 Industrial Applications and Services | Electromedical & Electrotherapeutic Apparatus | [
"OTC"
] | S-1/A | 2021-08-23 00:00:00 | 0001193125-21-254025 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844505/000119312521254025/d33994ds1a.htm | [] |
QT IMAGING HOLDINGS, INC. | [
"QTIWW"
] | 0001844505 | 3845 | 08 Industrial Applications and Services | Electromedical & Electrotherapeutic Apparatus | [
"OTC"
] | S-1/A | 2021-04-26 00:00:00 | 0001193125-21-131640 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844505/000119312521131640/d33994ds1a.htm | [] |
QT IMAGING HOLDINGS, INC. | [
"QTIWW"
] | 0001844505 | 3845 | 08 Industrial Applications and Services | Electromedical & Electrotherapeutic Apparatus | [
"OTC"
] | S-1/A | 2021-03-22 00:00:00 | 0001193125-21-087879 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844505/000119312521087879/d33994ds1a.htm | [] |
QT IMAGING HOLDINGS, INC. | [
"QTIWW"
] | 0001844505 | 3845 | 08 Industrial Applications and Services | Electromedical & Electrotherapeutic Apparatus | [
"OTC"
] | S-1 | 2021-03-09 00:00:00 | 0001193125-21-074922 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001844505/000119312521074922/d33994ds1.htm | [] |
Aspire Biopharma Holdings, Inc. | [
"ASBPW"
] | 0001847345 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2025-12-03 00:00:00 | 0001493152-25-025819 | true | ABOUT THIS PROSPECTUS; TRADEMARKS, TRADE NAMES AND SERVICE MARKS; MARKET AND INDUSTRY DATA; SELECTED DEFINITIONS; Cautionary Statement Regarding Forward-Looking Statements; PROSPECTUS SUMMARY; THE OFFERING; Risk Factors; TRANSACTION WITH ARENA; USE OF PROCEEDS; DETERMINATION OF OFFERING PRICE; DIVIDEND POLICY; MARKET INFORMATION; Management’s Discussion and Analysis of Financial Condition and Results of Operations; BUSINESS; Management; Executive and Director Compensation; CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS; PRINCIPAL STOCKHOLDERS; Selling Shareholders; Description of Capital Stock; SECURITIES ACT RESTRICTIONS ON RESALE OF COMMON STOCK; PLAN OF DISTRIBUTION (CONFLICT OF INTEREST); LEGAL MATTERS; EXPERTS; Where You Can Find More Information; INDEX TO CONSOLIDATED FINANCIAL STATEMENTS | false | ./parsed_sections/prospectus_summary/2025/ASBPW_aspire_prospectus_summary.txt | 13,614 | false | ./parsed_sections/risk_factors/2025/ASBPW_aspire_risk_factors.txt | 14,554 | false | ./parsed_sections/legal_matters/2025/ASBPW_aspire_legal_matters.txt | 27,648 | https://www.sec.gov/Archives/edgar/data/0001847345/000149315225025819/forms-1.htm | [] |
Aspire Biopharma Holdings, Inc. | [
"ASBPW"
] | 0001847345 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2025-09-26 00:00:00 | 0001493152-25-015778 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001847345/000149315225015778/forms-1a.htm | [] |
Aspire Biopharma Holdings, Inc. | [
"ASBPW"
] | 0001847345 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2025-09-18 00:00:00 | 0001493152-25-014085 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001847345/000149315225014085/forms-1.htm | [] |
Aspire Biopharma Holdings, Inc. | [
"ASBPW"
] | 0001847345 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2025-05-13 00:00:00 | 0001641172-25-010013 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001847345/000164117225010013/forms-1.htm | [] |
Aspire Biopharma Holdings, Inc. | [
"ASBPW"
] | 0001847345 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2025-04-09 00:00:00 | 0001641172-25-003291 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001847345/000164117225003291/forms-1.htm | [] |
Aspire Biopharma Holdings, Inc. | [
"ASBPW"
] | 0001847345 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1/A | 2022-02-14 00:00:00 | 0001104659-22-021776 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001847345/000110465922021776/tm219697d6_s1a.htm | [] |
Aspire Biopharma Holdings, Inc. | [
"ASBPW"
] | 0001847345 | 2834 | 03 Life Sciences | Pharmaceutical Preparations | [
"Nasdaq"
] | S-1 | 2021-12-30 00:00:00 | 0001104659-21-154391 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001847345/000110465921154391/tm219697d5_s1.htm | [] |
Lannister Mining Corp. | [] | 0001851535 | 1000 | 01 Energy & Transportation | Metal Mining | [] | F-1/A | 2025-12-12 00:00:00 | 0001213900-25-121192 | true | Glossary of Mining Terms; Prospectus Summary; Risk Factors; Special Note Regarding Forward-Looking Statements; Use of Proceeds; Dividend Policy; Capitalization; Dilution; Management’s Discussion and Analysis of Financial Condition and Results of Operations; Corporate History and Structure; Industry; Business; Regulations of Our Industry; Management; Principal Shareholders; Related Party Transactions; Description of Share Capital; Shares Eligible For Future Sale; Material United States and Canadian Income Tax Considerations; Enforceability of Civil Liabilities; Underwriting; Expenses Related to this Offering; Legal Matters; Experts; Where You Can Find More Information; Financial Statements | false | ./parsed_sections/prospectus_summary/2025/CIK0001851535_lannister_prospectus_summary.txt | 10,560 | false | ./parsed_sections/risk_factors/2025/CIK0001851535_lannister_risk_factors.txt | 13,228 | false | ./parsed_sections/legal_matters/2025/CIK0001851535_lannister_legal_matters.txt | 2,021 | https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/ea0268979-f1a5_lannister.htm | [
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_002.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_003.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_004.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_005.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_006.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_007.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_008.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_009.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_010.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_011.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_012.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_013.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_014.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_015.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_016.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_017.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_018.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_019.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_020.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_021.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_022.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_023.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_024.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_025.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_026.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_027.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_028.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_029.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_030.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_031.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/fin_001.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/fin_002.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/fin_003.jpg",
"https://www.sec.gov/Archives/edgar/data/0001851535/000121390025121192/image_032.jpg"
] |
Lannister Mining Corp. | [] | 0001851535 | 1000 | 01 Energy & Transportation | Metal Mining | [] | F-1/A | 2025-10-21 00:00:00 | 0001213900-25-100907 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001851535/000121390025100907/ea0260324-f1a4_lannister.htm | [] |
Lannister Mining Corp. | [] | 0001851535 | 1000 | 01 Energy & Transportation | Metal Mining | [] | F-1/A | 2025-08-05 00:00:00 | 0001213900-25-072122 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001851535/000121390025072122/ea0250681-f1a3_lannister.htm | [] |
Lannister Mining Corp. | [] | 0001851535 | 1000 | 01 Energy & Transportation | Metal Mining | [] | F-1/A | 2025-06-10 00:00:00 | 0001213900-25-053154 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001851535/000121390025053154/ea0244938-f1a2_lannister.htm | [] |
Lannister Mining Corp. | [] | 0001851535 | 1000 | 01 Energy & Transportation | Metal Mining | [] | F-1/A | 2025-05-02 00:00:00 | 0001213900-25-039123 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001851535/000121390025039123/ea0237056-f1a1_lannister.htm | [] |
Lannister Mining Corp. | [] | 0001851535 | 1000 | 01 Energy & Transportation | Metal Mining | [] | F-1 | 2024-07-31 00:00:00 | 0001013762-24-003297 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001851535/000101376224003297/ea0207369-f1_lannister.htm | [] |
Grayscale Chainlink Trust ETF | [
"GLNK"
] | 0001852025 | 6221 | 09 Crypto Assets | Commodity Contracts Brokers & Dealers | [
"NYSE"
] | S-1/A | 2025-11-12 00:00:00 | 0001193125-25-277993 | true | Forward-Looking Statements; Prospectus Summary; The Offering; Risk Factors; Use of Proceeds; Management’s Discussion and Analysis of Financial Condition and Results of Operations; Business; Key Personnel of the Sponsor; Certain Relationships and Related Party Transactions; Description of the Shares; Description of Creation and Redemption of Shares; Material U.S. Federal Income Tax Consequences; ERISA and Related Considerations; Plan of Distribution; Legal Matters; Experts; Where You Can Find More Information; Glossary of Defined Terms; Index to Financial Statements | false | ./parsed_sections/prospectus_summary/2025/GLNK_grayscale_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2025/GLNK_grayscale_risk_factors.txt | 38,741 | true | ./parsed_sections/legal_matters/2025/GLNK_grayscale_legal_matters.txt | 53 | https://www.sec.gov/Archives/edgar/data/0001852025/000119312525277993/link_s-1_amendment_1.htm | [
"https://www.sec.gov/Archives/edgar/data/0001852025/000119312525277993/img48691794_0.jpg",
"https://www.sec.gov/Archives/edgar/data/0001852025/000119312525277993/img48691794_1.jpg",
"https://www.sec.gov/Archives/edgar/data/0001852025/000119312525277993/img48691794_2.jpg",
"https://www.sec.gov/Archives/edgar/data/0001852025/000119312525277993/img48691794_3.jpg"
] |
Grayscale Chainlink Trust ETF | [
"GLNK"
] | 0001852025 | 6221 | 09 Crypto Assets | Commodity Contracts Brokers & Dealers | [
"NYSE"
] | S-1 | 2025-09-08 00:00:00 | 0001193125-25-197401 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001852025/000119312525197401/glnk-20250905.htm | [] |
Kodiak AI, Inc. | [
"KDKRW"
] | 0001853138 | 7373 | 06 Technology | Services-Computer Integrated Systems Design | [
"Nasdaq"
] | S-1/A | 2025-11-13 00:00:00 | 0001193125-25-280414 | true | About This Prospectus; Market and Industry Data; Trademarks; Prospectus Summary; Risk Factors; Cautionary Note Regarding Forward-Looking Statements; Use of Proceeds; Market Price of and Dividends on the Registrant’s Common Equity and Related Stockholder Matters; Unaudited Pro Forma Condensed Combined Financial Information; Management’s Discussion and Analysis of Financial Condition and Results of Operations; Business; Management; Executive Compensation; Certain Relationships, Related Party and Other Transactions; Principal Securityholders; Selling Securityholders; Description of Capital Stock; Securities Act Restrictions on Resale of Securities; Material U.S. Federal Income Tax Considerations; Plan of Distribution; Legal Matters; Experts; Where You Can Find Additional Information; Index to Financial Statements | true | ./parsed_sections/prospectus_summary/2025/KDKRW_kodiak-ai_prospectus_summary.txt | 1,617 | false | ./parsed_sections/risk_factors/2025/KDKRW_kodiak-ai_risk_factors.txt | 31,566 | true | ./parsed_sections/legal_matters/2025/KDKRW_kodiak-ai_legal_matters.txt | 61 | https://www.sec.gov/Archives/edgar/data/0001853138/000119312525280414/d46628ds1a.htm | [
"https://www.sec.gov/Archives/edgar/data/0001853138/000119312525280414/g46628g03a01.jpg",
"https://www.sec.gov/Archives/edgar/data/0001853138/000119312525280414/g46628g01g94.jpg",
"https://www.sec.gov/Archives/edgar/data/0001853138/000119312525280414/g46628g95a01.jpg",
"https://www.sec.gov/Archives/edgar/data/0001853138/000119312525280414/g46628g97a01.jpg",
"https://www.sec.gov/Archives/edgar/data/0001853138/000119312525280414/g46628g97a02.jpg",
"https://www.sec.gov/Archives/edgar/data/0001853138/000119312525280414/g46628g01g98.jpg"
] |
Kodiak AI, Inc. | [
"KDKRW"
] | 0001853138 | 7373 | 06 Technology | Services-Computer Integrated Systems Design | [
"Nasdaq"
] | S-1 | 2025-10-10 00:00:00 | 0001193125-25-237165 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001853138/000119312525237165/d46628ds1.htm | [] |
Kodiak AI, Inc. | [
"KDKRW"
] | 0001853138 | 7373 | 06 Technology | Services-Computer Integrated Systems Design | [
"Nasdaq"
] | S-1/A | 2023-04-18 00:00:00 | 0001193125-23-104842 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001853138/000119312523104842/d428850ds1a.htm | [] |
Kodiak AI, Inc. | [
"KDKRW"
] | 0001853138 | 7373 | 06 Technology | Services-Computer Integrated Systems Design | [
"Nasdaq"
] | S-1/A | 2023-04-14 00:00:00 | 0001193125-23-102303 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001853138/000119312523102303/d428850ds1a.htm | [] |
Kodiak AI, Inc. | [
"KDKRW"
] | 0001853138 | 7373 | 06 Technology | Services-Computer Integrated Systems Design | [
"Nasdaq"
] | S-1/A | 2023-04-07 00:00:00 | 0001193125-23-095360 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001853138/000119312523095360/d428850ds1a.htm | [] |
Kodiak AI, Inc. | [
"KDKRW"
] | 0001853138 | 7373 | 06 Technology | Services-Computer Integrated Systems Design | [
"Nasdaq"
] | S-1 | 2023-03-29 00:00:00 | 0001193125-23-083839 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001853138/000119312523083839/d428850ds1.htm | [] |
DevvStream Corp. | [
"DEVS"
] | 0001854480 | 6799 | 05 Real Estate & Construction | Investors, NEC | [
"Nasdaq"
] | S-1/A | 2025-11-26 00:00:00 | 0001140361-25-043382 | true | Prospectus Summary; Risk Factors; Market and Industry Data; Use of Proceeds; Determination of Offering Price; Market Information for Securities and Dividend Policy; Business; Management’s Discussion and Analysis of Financial Condition and Results of Operations; Management; Executive Compensation; Pay Versus Performance Table; Corporate Governance.; Certain Relationships and Related Party Transactions; Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters; Selling Stockholder; Description of Securities; Material U.S. Federal Income Tax Consequences; Plan of Distribution; Legal Matters; Experts; Where You Can Find More Information; Index to Consolidated Financial Statements | false | ./parsed_sections/prospectus_summary/2025/DEVS_devvstream_prospectus_summary.txt | 3 | false | ./parsed_sections/risk_factors/2025/DEVS_devvstream_risk_factors.txt | 17,784 | true | ./parsed_sections/legal_matters/2025/DEVS_devvstream_legal_matters.txt | 33 | https://www.sec.gov/Archives/edgar/data/0001854480/000114036125043382/ny20052991x7_s1a.htm | [
"https://www.sec.gov/Archives/edgar/data/0001854480/000114036125043382/logo_devvstream01.jpg",
"https://www.sec.gov/Archives/edgar/data/0001854480/000114036125043382/logo_davidson.jpg",
"https://www.sec.gov/Archives/edgar/data/0001854480/000114036125043382/logo_nexiafooter.jpg",
"https://www.sec.gov/Archives/edgar/data/0001854480/000114036125043382/logo_mnp01.jpg",
"https://www.sec.gov/Archives/edgar/data/0001854480/000114036125043382/logo_mnp01x1.jpg"
] |
DevvStream Corp. | [
"DEVS"
] | 0001854480 | 6799 | 05 Real Estate & Construction | Investors, NEC | [
"Nasdaq"
] | S-1/A | 2025-10-20 00:00:00 | 0001140361-25-038679 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001854480/000114036125038679/ny20052991x4_s1a.htm | [] |
DevvStream Corp. | [
"DEVS"
] | 0001854480 | 6799 | 05 Real Estate & Construction | Investors, NEC | [
"Nasdaq"
] | S-1/A | 2025-09-30 00:00:00 | 0001140361-25-036776 | false | null | null | null | null | null | null | null | null | null | null | https://www.sec.gov/Archives/edgar/data/0001854480/000114036125036776/ny20052991x2_s1a.htm | [] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.